Definium Therapeutics, Inc. (DFTX)Healthcare | Biotechnology | New York, United States | NasdaqGS
43.65 USD
-3.42
(-7.266%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 44.00 +0.35 (0.802%) ⇧ (July 13, 2026, 7:52 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:20 a.m. EDT
The narrative here is a classic biotech turnaround story fueled by a massive Phase 3 win and a fresh capital raise. While the company is burning cash and lacks profitability, the balance sheet is surprisingly robust with minimal debt and ample cash reserves, allowing them to weather the storm while waiting for commercialization. The recent price surge and the $805 million offering suggest the market is pricing in a successful path to approval and eventual revenue. However, the statistical forecasting model is completely useless here, showing very low confidence and zero predictive power, which is typical for event-driven biotech stocks where binary outcomes dominate price action. The options market is screaming for upside, betting on a continuation of the rally toward $60, while the fundamental reality remains that this is still a high-risk venture with no guaranteed product launch date. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.106693 |
| MSTL | 0.108456 |
| AutoTheta | 0.128909 |
| AutoARIMA | 0.177947 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 18% |
| H-stat | 28.18 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 3.92 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 14.622 |
| Market Cap | 5,794,243,072 |
| Forward P/E | -28.89 |
| Beta | 2.21 |
| Previous Name | Mind Medicine (MindMed) Inc. |
| Website | https://definiumtx.com |
As of July 11, 2026, 4:20 a.m. EDT: Speculators are aggressively positioning for a breakout above the $47-$50 resistance zone. Call volume spikes significantly at strikes $50, $55, and $60, with the $60 strike showing massive new inflow relative to open interest, suggesting a bet on a rapid move to $60+. Conversely, put activity is concentrated deep in-the-money (below $20) and at the immediate support level ($45-$47), indicating a 'floor' defense strategy rather than a bearish crash thesis. Implied volatility remains elevated across the board, reflecting uncertainty around the upcoming catalysts.
| Attribute | Value |
|---|---|
| 52 Week Change | 4.65066 |
| Address1 | One World Trade Center |
| Address2 | Suite 8500 |
| All Time High | 86.55 |
| All Time Low | 0.015 |
| Ask | 56.11 |
| Ask Size | 2 |
| Audit Risk | 7 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 3,954,030 |
| Average Daily Volume3 Month | 2,937,981 |
| Average Volume | 2,937,981 |
| Average Volume10Days | 3,954,030 |
| Beta | 2.212 |
| Bid | 32.65 |
| Bid Size | 2 |
| Board Risk | 3 |
| Book Value | 2.68 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 43.65 |
| Current Ratio | 4.692 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 46.41 |
| Day Low | 43.38 |
| Debt To Equity | 14.622 |
| Display Name | Definium Therapeutics |
| Earnings Call Timestamp End | 1,778,185,800 |
| Earnings Call Timestamp Start | 1,778,185,800 |
| Earnings Timestamp | 1,778,184,000 |
| Earnings Timestamp End | 1,785,441,600 |
| Earnings Timestamp Start | 1,785,441,600 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 4,428,115,968 |
| Eps Current Year | -2.2325 |
| Eps Forward | -1.51091 |
| Eps Trailing Twelve Months | -2.5 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 28.67 |
| Fifty Day Average Change | 14.980001 |
| Fifty Day Average Change Percent | 0.5224974 |
| Fifty Two Week Change Percent | 465.066 |
| Fifty Two Week High | 49.2 |
| Fifty Two Week High Change | -5.549999 |
| Fifty Two Week High Change Percent | -0.11280486 |
| Fifty Two Week Low | 7.96 |
| Fifty Two Week Low Change | 35.690002 |
| Fifty Two Week Low Change Percent | 4.483669 |
| Fifty Two Week Range | 7.96 - 49.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,479,220,200,000 |
| Float Shares | 107,083,949 |
| Forward Eps | -1.51091 |
| Forward P E | -28.889875 |
| Free Cashflow | -45,625,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 105 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.013300001 |
| Held Percent Institutions | 0.65834 |
| Implied Shares Outstanding | 132,743,254 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,661,731,200 |
| Last Split Factor | 1:15 |
| Long Business Summary | Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York. |
| Long Name | Definium Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 5,794,243,072 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_631045282 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -237,543,008 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 6,248,224,965 |
| Number Of Analyst Opinions | 15 |
| Open | 46.0 |
| Operating Cashflow | -144,772,000 |
| Operating Margins | 0.0 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 212 220 6633 |
| Post Market Change | 0.34999847 |
| Post Market Change Percent | 0.8018292 |
| Post Market Price | 44.0 |
| Post Market Time | 1,783,986,733 |
| Prev Name | Mind Medicine (MindMed) Inc. |
| Previous Close | 47.07 |
| Price Eps Current Year | -19.552073 |
| Price Hint | 2 |
| Price To Book | 16.287313 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.604 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.26667 |
| Region | US |
| Regular Market Change | -3.42 |
| Regular Market Change Percent | -7.26577 |
| Regular Market Day High | 46.41 |
| Regular Market Day Low | 43.38 |
| Regular Market Day Range | 43.38 - 46.41 |
| Regular Market Open | 46.0 |
| Regular Market Previous Close | 47.07 |
| Regular Market Price | 43.65 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 1,806,875 |
| Return On Assets | -0.35724 |
| Return On Equity | -0.94704 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 132,743,254 |
| Shares Percent Shares Out | 0.1094 |
| Shares Short | 14,517,267 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 9,425,925 |
| Short Name | Definium Therapeutics, Inc. |
| Short Percent Of Float | 0.1101 |
| Short Ratio | 3.05 |
| Source Interval | 15 |
| State | NY |
| Symbol | DFTX |
| Target High Price | 74.0 |
| Target Low Price | 48.0 |
| Target Mean Price | 57.8 |
| Target Median Price | 57.0 |
| Total Cash | 373,422,016 |
| Total Cash Per Share | 3.424 |
| Total Debt | 40,773,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.5 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 18.70255 |
| Two Hundred Day Average Change | 24.94745 |
| Two Hundred Day Average Change Percent | 1.3339063 |
| Type Disp | Equity |
| Volume | 1,806,875 |
| Website | https://definiumtx.com |
| Zip | 10,007 |